Areas of Focus
Innovative science is our passion. Transformational medicines are our goal. Bristol-Myers Squibb is committed to discovering, developing and delivering transformational medicines in areas where we believe we have an opportunity to make a meaningful difference for patients: oncology, immunoscience, cardiovascular and fibrosis.
Our vision for the future of cancer care is focused on researching and developing transformational oncology medicines . . .
Bristol-Myers Squibb is committed to developing transformational therapies that will lead to long-lasting remission . . .
We are expanding our innovation in cardiovascular disease to focus on underserved areas with a concentration on highly validated targets . . .
We are researching novel medicines that have the potential to halt or reverse progression of tissue scarring that impacts organ function . . .
Biologics are large molecules produced from living organisms . . .
These are organic compounds that are relatively small in size . . .
Millamolecules are mid-range compounds that fall in size between small molecules and biologics . . .
By tethering a small molecule to a biologic, antibody-drug conjugates are engineered . . .
Gene therapy delivers modified DNA to correct, repair or replace a defective disease-causing gene . . .
Short strands of nucleic acids synthesized . . .
Drug Delivery Technology
Novel technologies that will safely and effectively deliver . . .